Agios to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ: AGIO) announced its participation in the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on June 23, 2020, at 9:00 a.m. ET. The presentation will highlight the company's advancements in cellular metabolism treatments for cancer and rare genetic diseases. Interested parties can view a live webcast on Agios's website under the 'Events & Presentations' section, with a replay available for two weeks post-event. Agios is known for its innovative investigational medicines and precision therapies in oncology.

CAMBRIDGE, Mass., June 17, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020 at 9:00 a.m. ET.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com.

Contacts

Investors:
Holly Manning, 617-844-6630
Director, Investor Relations
Holly.Manning@agios.com

Media:
Jessica Rennekamp, 857-209-3286
Associate Director, Corporate Communications
Jessica.Rennekamp@agios.com

FAQ

When is Agios Pharmaceuticals presenting at the BMO 2020 Conference?

Agios Pharmaceuticals is scheduled to present on June 23, 2020, at 9:00 a.m. ET.

Where can I access the Agios Pharmaceuticals conference presentation?

The presentation can be accessed via a live webcast on Agios's website under the 'Events & Presentations' section.

How long will the Agios Pharmaceuticals presentation replay be available?

The replay of the presentation will be available for at least two weeks following the event.

What areas does Agios Pharmaceuticals focus on in its research?

Agios focuses on discovering medicines for malignant hematology, solid tumors, and rare genetic diseases.

What is the stock symbol for Agios Pharmaceuticals?

The stock symbol for Agios Pharmaceuticals is AGIO.